- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
BVI purchases ophthalmic assets from Odyssey
Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions.
Waltham, MA-Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions. BVI is a portfolio company of RoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry.
“We are excited to bring Odyssey to our customers as a part of the Beaver-Visitec family,” said Tom Kapfer, chief executive officer of BVI. “We are committed to providing high-quality single-use products with the performance and precision clinicians expect. Odyssey is a perfect fit with our goal.”
"BVI and Odyssey both believe in offering the best products to our customers,” added Barbara Tatge, a former owner of Odyssey who will be joining BVI. “This shared value is what attracted us to BVI.”
For more articles in this issue of Ophthalmology Times eReport, click here.
